Viridian Therapeutics, Inc.\DE (VRDN) Profit After Tax: 2014-2025
Historic Profit After Tax for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Sep 2025 value amounting to -$34.6 million.
- Viridian Therapeutics, Inc.\DE's Profit After Tax rose 54.88% to -$34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$302.0 million, marking a year-over-year decrease of 17.46%. This contributed to the annual value of -$269.9 million for FY2024, which is 13.55% down from last year.
- Viridian Therapeutics, Inc.\DE's Profit After Tax amounted to -$34.6 million in Q3 2025, which was up 65.65% from -$100.7 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Profit After Tax ranged from a high of -$14.0 million in Q3 2021 and a low of -$100.7 million during Q2 2025.
- In the last 3 years, Viridian Therapeutics, Inc.\DE's Profit After Tax had a median value of -$66.9 million in 2023 and averaged -$66.4 million.
- Examining YoY changes over the last 5 years, Viridian Therapeutics, Inc.\DE's Profit After Tax showed a top increase of 68.10% in 2021 and a maximum decrease of 179.16% in 2021.
- Quarterly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Profit After Tax stood at -$28.9 million in 2021, then crashed by 58.17% to -$45.8 million in 2022, then crashed by 46.03% to -$66.9 million in 2023, then declined by 19.24% to -$79.7 million in 2024, then soared by 54.88% to -$34.6 million in 2025.
- Its last three reported values are -$34.6 million in Q3 2025, -$100.7 million for Q2 2025, and -$86.9 million during Q1 2025.